Stockreport

Arcutis (ARQT) Announces Long-Term Phase 3 Data for ZORYVE Cream in Children [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF Arcutis Biotherapeutics Inc. (NASDAQ: ARQT ) is one of the best growth stocks to buy right now . On March 10, Arcutis Biotherapeutics announced the publication of long- [Read more]